AstraZeneca strikes deal with Oxford University to mass produce experimental COVID-19 vaccine

Pharmaceutical giant AstraZeneca strikes deal with Oxford University to mass produce experimental COVID-19 vaccine with first results from human trials expected in June The agreement was announced this morning, with the details set to be finalised  It will allow for rapid vaccination around the world, if the jab is proven to work And it will … Read more

AstraZeneca to start Calquence in COVID-19 trial

What is the coronavirus?  A coronavirus is a type of virus which can cause illness in animals and people. Viruses break into cells inside their host and use them to reproduce itself and disrupt the body’s normal functions. Coronaviruses are named after the Latin word ‘corona’, which means crown, because they are encased by a … Read more

Drugs giant AstraZeneca in talks with governments to find cure for virus

Drugs giant AstraZeneca in talks with governments to find cure for virus Research agreements could be announced in the coming days A deal would see the company team up with experts on monoclonal antibodies  By Jamie Nimmo For The Financial Mail On Sunday Published: 23:05 GMT, 21 March 2020 | Updated: 23:05 GMT, 21 March … Read more

IN THE MONEY: AstraZeneca boss Pascal Soriot to get £7m in shares

IN THE MONEY: AstraZeneca boss Pascal Soriot to get £7m in shares if he hits his targets By Daily Mail City & Finance Reporter Published: 22:44 GMT, 10 March 2020 | Updated: 22:44 GMT, 10 March 2020 Astrazeneca boss Pascal Soriot has been granted more than £7million worth of shares. The 60-year-old, who has been … Read more

Astrazeneca shares fall after it warns that coronavirus epidemic will hit business

Astrazeneca shares fall after it warns that coronavirus epidemic will hit business for ‘up to a few months’ By Daily Mail City & Finance Reporter Published: 21:48 GMT, 14 February 2020 | Updated: 08:48 GMT, 16 February 2020 Astrazeneca shares fell after it warned that the coronavirus epidemic will hit the business for ‘up to … Read more